• Nenhum resultado encontrado

[PDF] Top 20 Peculiarities of bone metabolism in patients with multiple myeloma

Has 10000 "Peculiarities of bone metabolism in patients with multiple myeloma" found on our website. Below are the top 20 most common "Peculiarities of bone metabolism in patients with multiple myeloma".

Peculiarities of bone metabolism in patients with multiple myeloma

Peculiarities of bone metabolism in patients with multiple myeloma

... Multiple myeloma is one of the most widespread hemoblastosis. in the structure of oncohematology it takes up about ...follows with destruction of bones and results ... See full document

5

The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease.

The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease.

... Multiple myeloma is one of the most common hematological diseases and is characterized by an aberrant proliferation of plasma cells within the bone ...result of crosstalk between ... See full document

17

Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus

Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus

... measurement of BMD by dual-energy x-ray absorptiometry (DEXA) as an index of bone strength and fracture risk, has been used in postmenopausal women ...distribution of BMD follows a ... See full document

11

Multiple myeloma with cells typically seen in storage diseases

Multiple myeloma with cells typically seen in storage diseases

... stained bone marrow aspirate smears showed 7 per cent of typical myeloma plasma cells and 20% of atypical large cells containing a great amount of azurophilic inclusions usually seen ... See full document

1

Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study

Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study

... reduce bone pain, improve quality of life and decrease the incidence of SREs, including radiation to bone, thereby reducing ...alleviate bone pain and delay the need for radiation to ... See full document

8

Observational study of multiple myeloma in Latin America

Observational study of multiple myeloma in Latin America

... ineligible patients treated with current regimens [19–22] and typically longer in the transplantation setting [17, 18], in which the adoption of an Boptimal strategy^ is expected to ... See full document

8

Rev. Bras. Hematol. Hemoter.  vol.36 número1

Rev. Bras. Hematol. Hemoter. vol.36 número1

... studies in Brazil that have assessed first-line induction therapy with two or three agents for patients with multiple myeloma, regardless of their eligibility for ... See full document

6

Multiples aberrant phenotypes in multiple myeloma patient expressing CD56-, CD28+,CD19+

Multiples aberrant phenotypes in multiple myeloma patient expressing CD56-, CD28+,CD19+

... expression of aberrant antigens in myeloma plasma cells (MPCs) is a common ...antigens in MPCs are: CD56 (75%) and CD117 ...that multiple myeloma (MM) patients with ... See full document

2

Clinics  vol.63 número2

Clinics vol.63 número2

... treating patients with multiple myeloma or metastatic breast cancer based on study findings that pamidronate reduces the risk of skeletal ...complications. In 2002, intravenous ... See full document

4

BIOCHEMICAL PROFILE AND ELECTROPHORETIC PATTERN IN  MULTIPLE MYELOMA PATIENTS

BIOCHEMICAL PROFILE AND ELECTROPHORETIC PATTERN IN MULTIPLE MYELOMA PATIENTS

... profile of 94 diagnosed case of Multiple ...protein in the diagnosed cases was ...seen in 62% cases while hypoproteinemia <6.4gm/dL was seen in 2% ...case. In one case ... See full document

5

Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma.

Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma.

... Measurement of sRANKL in serum showed that 5T2MM- bearing mice had high circulating levels of sRANKL in all tumour- bearing ...mice. In contrast, sRANKL was not detectable in the ... See full document

10

FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells

FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells

... proportion of polyfunc- tional Th17-1 cells than peripheral blood, and these cells were not observed in MGUS BM ...role in MM immune dysfunc- ...eration of Th17 cells, Prabhala et ...frequency ... See full document

9

Double filtration plasmapheresis in a dog with multiple myeloma and hyperviscosity syndrome

Double filtration plasmapheresis in a dog with multiple myeloma and hyperviscosity syndrome

... instead of citrate (Ismail et al., 2007). On the basis of our first clinical experience, DFPP seemed to have a good efficacy to remove the excess of globulins and total protein, as previously ... See full document

5

Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients

Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients

... impact of multiple myeloma on the quality of life of patients treated in two public institutions in Sa˜o Paulo State, Brazil, using a generic Short Form 36 Health ... See full document

5

Rev. Bras. Reumatol.  vol.51 número4 en v51n4a12

Rev. Bras. Reumatol. vol.51 número4 en v51n4a12

... inhibitors of bone resorption, and are used in the treatment of osteoporosis and other diseases that cause bone mass loss, such as Paget’s disease, bone metastases, and ... See full document

4

Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis

Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis

... use of supplements containing vitamin D was not associated with serum 25(OH)D concentrations, with low values even in patients receiving ...dose of vitamin D for patients ... See full document

5

Changes in circulating endothelial progenitor cells predict responses of multiple myeloma patients to treatment with bortezomib and dexamethasone

Changes in circulating endothelial progenitor cells predict responses of multiple myeloma patients to treatment with bortezomib and dexamethasone

... for multiple myeloma (MM) stem cell transplant and non-transplant ...cycles of the regimen, the rate of complete response (CR)/near CR was ...rate of achieving at least a very good ... See full document

7

O transplante alogênico de células-tronco hematopoéticas no tratamento do Mieloma Múltiplo.

O transplante alogênico de células-tronco hematopoéticas no tratamento do Mieloma Múltiplo.

... Cure of multiple myeloma -- more hype, less reality. Bone Marrow Transplant ...Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic ... See full document

6

Contents lists available at ScienceDirect

Contents lists available at ScienceDirect

... associated with PFs in patients with bone metastases or lesions from Austria, the Czech Republic, Finland, Greece, Poland, Portugal, Sweden and ...Switzerland. Patients eligible ... See full document

9

Multiple Myeloma in a Patient with Acromegaly

Multiple Myeloma in a Patient with Acromegaly

... (IFE) of serum samples revealed a monoclonal gam- mopathy (M peak 4.9 g/dL) of immunoglobulin G (IgG)-λ type; PEP and IFE of urine samples were inadequate because of low urinary ...nosis ... See full document

6

Show all 10000 documents...